Nectar Lifescience Ltd Nine Monthly Results

Gross Sales

1,419.08

1,414.15

1,300.53

1,378.09

1,355.72

Excise Duty

178.01

169.91

164.76

185.49

161.91

Net Sales

1,241.07

1,244.24

1,135.78

1,192.61

1,193.81

Other Operating Income

1.31

0.02

0.02

0.02

1.78

Other Income

1.81

11.56

24.31

10.77

1.7

Total Income

1,244.19

1,255.82

1,160.11

1,203.4

1,197.29

Total Expenditure

1,114.53

1,139.66

1,099.94

1,083.21

1,114.71

PBIDT

129.66

116.16

60.17

120.19

82.59

Interest

56.91

62.98

59.82

61.38

86.39

PBDT

72.75

53.17

0.35

58.81

-3.8

Depreciation

46.62

46.02

44.27

42.71

45.25

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

9.72

2.75

-16.06

2.71

-16.76

Reported Profit After Tax

16.41

4.4

-27.86

13.39

-32.29

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

16.41

4.4

-27.86

13.39

-32.29

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

16.41

4.4

-27.86

13.39

-32.29

EPS (Unit Curr.)

0.73

0.2

-1.24

0.6

-1.44

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.43

22.43

22.43

22.43

22.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.44

9.33

5.29

10.07

6.91

PBDTM(%)

5.86

4.27

0.03

4.93

-0.31

PATM(%)

1.32

0.35

-2.45

1.12

-2.7